The aim was to determine the mechanisms facilitating exercise performance in hot conditions following 21 heat training. In a counter-balanced order seven males (V O 2 max 61.2±4.4 ml. determined. Prior to one set of exercise tests in T38 blood volume was acutely expanded by 538±16 ml 27 with an albumin solution (T38 A ) to determine the role of acclimatization induced hypervolemia on 28 exercise performance. We furthermore hypothesized that heat training would restore MCAv mean and 29 thereby limit centrally mediated fatigue. V O 2 max and Time Trial performance were equally reduced in 30 T38 and T38 A (7.2±1.6 and 9.3±2.5 % for V O 2 max; 12.8±2.8 and 12.9±2.8 % for Time Trial). Following 31 heat training both were increased in T38 (9.6±2.1 and 10.4±3.1 %, respectively) whereas both V O 2 max 32 and Time Trial performance remained unchanged in T18. As expected heat training augmented plasma 33 volume (6±2 %) and mean sweat output (26±6 %) whereas sweat [Na + ] became reduced by 19±7 %. In 34 T38 Q max remained unchanged pre (21.3±0.6 l.min -1 ) to post (21.7±0.5 l.min -1 ) training whereas 35 MCAv mean was increased by 13±10 %. However, none of the observed adaptations correlated with the 36 concomitant observed changes in exercise performance. 37 38
either 10 days of 90 min exercise training in 18 or 38 °C ambient temperature (30 % relative humidity) 23 applying a cross-over design. Participants were tested for V O 2 max and 30 min Time Trial performance in 24 18 (T18) and 38 (T38) °C before and after training. Blood volume parameters, sweat output, cardiac 25 output (Q ), cerebral perfusion (i.e. middle cerebral artery velocity [MCAv mean ]) and other variables were 26 determined. Prior to one set of exercise tests in T38 blood volume was acutely expanded by 538±16 ml 27 with an albumin solution (T38 A ) to determine the role of acclimatization induced hypervolemia on 28 exercise performance. We furthermore hypothesized that heat training would restore MCAv mean and 29 thereby limit centrally mediated fatigue. V O 2 max and Time Trial performance were equally reduced in 30 T38 and T38 A (7.2±1.6 and 9.3±2.5 % for V O 2 max; 12.8±2.8 and 12.9±2.8 % for Time Trial). Following 31 heat training both were increased in T38 (9.6±2.1 and 10.4±3.1 %, respectively) whereas both V O 2 max 32 and Time Trial performance remained unchanged in T18. As expected heat training augmented plasma 33 volume (6±2 %) and mean sweat output (26±6 %) whereas sweat [Na + ] became reduced by 19±7 %. In 34 T38 Q max remained unchanged pre (21.3±0.6 l.min -1 ) to post (21.7±0.5 l.min -1 ) training whereas 35
Introduction 46
Endurance exercise performance is impaired with acute exposure to warm environments but gradually 47
Such albumin infusion has been reported to expand and maintain an individuals' PV for > 6 h (9). Blood 164 pressure and HR were continuously monitored to ensure participants' well-being. After completion of the 165 expansion and as soon as participants felt ready the exercise performance tests were initiated as described 166 above. 167
168

Training intervention 169
The training loads were set corresponding to the HR elicited at 50 % of T18 and T38 V O 2 max with the 170 intent to assure the same relative cardiovascular strain in both conditions. Each training session lasted 90 171 min and was conducted on 10 consecutive days which is considered sufficient to trigger substantial heat 172 acclimation. To minimize dehydration, every 30 min participants were provided with 0.5 L of a 173 carbohydrate and electrolyte enriched drink (Isostar ® ) independent of whether they trained in hot or 174 temperate conditions. 175
176
Experimental measures 177
Throughout each test T rec was measured as a surrogate for T core . A flexible rectal probe (YSI M401AC, 178 Advanced Industrial Systems, Louisville, KY, USA), was self-inserted by the participant approximately 7 179 cm behind the anal sphincter. Additionally three skin temperature probes (YSI M409AC, Advanced 180 Industrial Systems, Louisville, KY, USA) were placed on the forehead, the lower back and the right 181 quadriceps. The average of the three locations was considered as mean skin temperature (T skin ). HR was 182 assessed using a monitor belt (Cosmed, Rome, Italy) and mean arterial pressure (MAP) was measured 183 noninvasively by means of finger photoplethysmography (Nexfin, BMEYE B.V, Amsterdam, 184 Netherlands). 185
During the V O 2 max test participants breathed through a mouthpiece (Hans Rudolph, Shawnee, KS, USA) 186 with their nose occluded wearing a nose clip. Ventilatory variables were measured breath-by-breath using 187 an indirect calorimeter (Cosmed Quark CPET, Rome, Italy) consisting of a flow meter and fast 188 responding gas analysers. Prior to each experimental session the system was calibrated using a 3-L 189 calibration syringe (Cosmed, Rome, Italy) and gas mixtures of known concentrations of O 2 and CO 2 . 190 After the test all data points were averaged over the last 30 s of each workload. with the Innocor M400 device (Innovision, Glamsbjerg, Denmark), which is based on an inert gas 194 rebreathing technique previously described elsewhere (42). When a measurement is initiated participants 195 are switched from breathing room air to the closed circuit and breathe a known gas mixture for 3 breaths 196 which concentration allows making predictions about Q . Measurements are based on the assumption that 197 pulmonary uptake of blood soluble testing gas is proportional to pulmonary blood flow which in turn can 198 be considered equal to cardiac output. The highest obtained value was defined as Q max and SV max , 199
respectively. 200
MCAv mean was assessed as an estimate of cerebral blood flow (CBF) using transcranial Doppler 201 ultrasonography (Doppler Box, DWL, Singen, Germany). A 2 MHz probe prepared with ultrasound gel 202 was adjusted over the temporal window to insonate the right MCA and was held in place with a snug-203 fitting headgear. Great care was taken that MCAv mean was always assessed at the same angle, position 204 (pictures were taken for this) and depth. Cerebral tissue oxygenation (ScO 2 ) was monitored by near infra-205 red spectroscopy (NIRS; INVOS-5100c, Covidien, Minneapolis, MN, USA) on the left forehead. Dry, nude body weight was determined at the beginning and at the end of each exercise test and training 209 session by a precision weighing balance to the nearest 0.1 kg (Kern MPB300K100, Balingen, Germany). 210
After correcting for fluid intake and time, the weight difference before and after the tests or trainings was 211 considered as sweat output. 212
Sweat samples were obtained during the training sessions on days 1 and 10 after 30, 60 and 90 min of 213 exercise. First the skin area between the scapulae was cleared with ultra-pure water (Milli Q, 18.2 MΩ 214 ionic purity). A cotton tissue was then placed on the same area and fixed with tape. After 5 minutes the 215 cotton tissue was removed and squeezed and transferred in to a syringe (Pico 50, Radiometer, Brønshøj, 216 Denmark PV, red blood cell volume (RBCV) and total blood volume (BV) was estimated with a CO re-breathing 219 method introduced by Burge and Skinner (4) but included small modifications. Briefly, participants were 220 positioned on a bed with elevated legs to facilitate venous return (18). Then, a 18-G catheter was placed 221 in an antecubital vein and participants were asked to drink 0.5 l of water. This was followed by a 4 min 222 period were participants breathed 100 % oxygen. While participants were still connected to the oxygen a 223 blood sample was taken and analyzed in quadruplicate for the fraction of carboxyhemoglobin (HbCO) 224 and hemoglobin concentration ([Hb]) on a hemoximeter (ABL800, Radiometer, Copenhagen, Denmark) 225 and for hematocrit (Hct) by the micro-method (4 min at 13,500 rpm). Immediately afterwards participants 226 were switched to a closed re-breathing circuit and breathed 1.5 ml.kg -1 of 99.997 % chemically pure CO 227 (CO N47, Air Liquide, Pullach, Germany) for 10 min. After these 10 min another blood sample was taken 228 and analyzed the same way as the first one. Finally, BV parameters could be derived from these variables 229 (4). In this study the coefficient of variance, expressed as percent typical error (15), was 1.8 % for Hb mass 230 and 3.8 % for PV. 231
Statistical analysis 233
Single differences between the T18, T38 and the T38 A trial were evaluated with a 1-way ANOVA for 234 repeated-measures whereas a repeated 2-way ANOVA design with exercise intensity (Rest, 80 W, 130 W, 235 160 W, 190 W, 220 W, 250 W, 280 W, Max) and condition (T18, T3, T38 A ) as main effects was applied 236 for the parameters recorded at different intensities. To detect changes from pre to post again a 2-way 237 ANOVA for repeated-measures with 2 times (pre and post) and 2 interventions (experimental and control) 238 was performed. The parameters recorded at different intensities were analyzed with a 3-way ANOVA 239 with the additional main effect of intensity (Rest, 80 W, 130 W, 160 W, 190 W, 220 W, 250 W, 280 W, 240 Max). Tukey's range test was applied for post hoc analysis after a significant F main effect and 241 interaction. Where appropriate, single comparisons were made using a paired t-test. Bivariate associations 242
were determined by Pearson's Correlation Coefficients where r = 0.1 represents a small, r = 0.3 a 243 moderate and r = 0.5 a large correlation. A P-value < 0.05 was considered statistically significant. Effect-244 sizes were described using Cohen's d (with d ≤ 0.2 representing a trivial difference; 0.2 -0.5, a small 245 difference; 0.5 -0.8 a moderate difference; and > 0.8 a large difference). Data is expressed as mean ± 246 SEM unless otherwise indicated. Statistical analysis was performed using SAS Enterprise Guide (4.3, 247 SAS Institute, Inc., Cary, NC, USA). 248
Results
250
One volunteer withdrew from the study after completing the first block due to personal reasons. 251 Therefore, the experimental group consisted of seven participants. The T38 A trial (conducted prior to the 252 exercise training intervention) however was completed by all eight volunteers. 253
254
Exercise performance with acute heat exposure following plasma volume expansion 255 W max (Figure 2A ), V O 2 max ( Figure 2B ) and P avg ( Figure 2C ) were highest when conducted during the T18 256 trial. Compared to T18, W max was decreased by 7.6 ± 1.5 and 9.0 ± 2.1 % (both P < 0.01) in T38 and 257 T38 A . The corresponding reduction in V O 2 max was 7.2 ± 1.6 and 9.3 ± 2.5 % (P < 0.05), respectively. 258 P avg was reduced by 12.8 ± 2.8 and 12.9 ± 2.8 % (both P < 0.05) in T38 and T38 A . W max , V O 2 max and P avg 259 during the T38 and T38 A trials were similar (P > 0.99, P = 0.9 and P > 0.99, respectively). 260 Figure 3 illustrates HR, SV and Q assessed during the V O 2 max test. Overall HR was higher (P < 0.01) 261 during the T38 compared to the T18 trial. HR was decreased (P < 0.01) in the T38 A trial compared to the 262 T38 trial but still elevated (P < 0.01) compared to the T18 trial. Overall, albumin infusion led to a higher 263 (P < 0.01) SV and Q compared to the T18 and T38 trial. Furthermore, overall SV but not Q was decreased 264 (P < 0.01 and P = 0.97, respectively) when conducted during the T38 trial compared to the T18 trial. The 265 same applied for SV max and Q max which were enhanced (P < 0.01) with albumin infusion compared to the 266 T18 and T38 trial but did not differ (P = 0.53, P = 0.78) between T18 and T38. 267
Albumin infusion did not alter VE (P = 0.38) in the T38 A V O 2 max test when compared to the T38 trial. 268 MAP was increased (P < 0.01) in the T38 A trial compared to the T38 trial but was still reduced (P < 0.01) 269 compared to the T18 trial. MCAv mean was also reduced in the T38 trial compared to the T18 trial. With 270 albumin infusion, however, MCAv mean was restored to the same level as in the T18 trials throughout the 271 entire exercise test (P = 0.96). 272
Detailed thermoregulatory parameters of all three trials are displayed in table 1. Briefly, due to the 273 passively induced hyperthermia prior to exercise, resting T rec and T skin reached higher (P < 0.05 for T rec 274 and P < 0.01 for T skin ) levels during the T38 and T38 A trial than in the T18 trial. Furthermore, during the 275 T38 and T38 A , trial maximal T rec and T skin were higher (P < 0.05) compared to the T18 trial in the Time 276
Trial but not in the V O 2 max test for T rec (P = 0.53 and P = 0.37, respectively). Albumin infusion did not 277 lead to a reduction (P > 0.99, P = 0.15) in maximal T rec and T skin compared to the T38 trial. 278
279
Effects of heat training on exercise performance when conducted in 18 and 38 °C 280 Figure 4 summarizes the mean performance responses for each test and for both groups. Before heat 281 training, a hyperthermia induced reduction in W max (8.5 ± 2.2 %, P < 0.01), V O 2 max (4.1 ± 1.4 %, P < 282 0.05) and P avg (13.1 ± 2.9 %, P < 0.01) was apparent in the T38 trial compared to the T18 trial. There was 283 a significant main effect of time and time*intervention interaction from pre to post when conducted at 38 284 °C for W max , V O 2 max and Time Trial P avg . In the experimental group W max increased by 7.9 ± 1.7 % (311 285 ± 13 vs. 335 ± 12 W, P < 0.01, d = 0.74) and V O 2 max by 9.6 ± 2.1 % (4.3 ± 0.2 vs. 4.8 ± 9.2 l.min -1 , P < 286 0.05, d > 0.80) and P avg by 10.4 ± 3.1 % (208 ± 12 vs. 228 ± 11 W, P < 0.01, d = 0.63). In contrast neither 287
were elevated compared to pre heat training when tested in T18, as there was no main effect of time (P = 288 0.19 for W max , P = 0.11 for V O 2 max, and P = for 0.32 for P avg ) or intervention (P = 0.61 for W max , P = 289 0.22 for V O 2 max, and P = 0.27 for P avg ), and no interaction of the two (P = 0.52 for W max , P = 0.57 for 290 V O 2 max and P = 0.64 for P avg ) from pre to post (340 ± 13 vs. 350 ± 10 W, d = 0.32 for W max , 4.5 ± 0.2 vs. 
Blood volume parameters 294
The expansion of PV with albumin by 15 % corresponded to an increase (P < 0.01) in PV of 538 ± 16 ml. 295
This was more (P < 0.05) than the corresponding increase induced by heat training (6 ± 2 %, 201 ± 88ml). 296
Nonetheless, the results of the CO re-breathing revealed a significant time*intervention interaction (P < 297 0.05), due to an increase in PV for the experimental group (+ 6 ± 2 % from 3370 ± 115 to 3571 ± 169 ml, 298 P < 0.05, d = 0.53) but an unaltered PV for the control group (3524 ± 128 vs. 3467 ± 135 ml, P = 0.80, d 299 = 0.15). 300
Heat training did not affect RBCV (2563 ± 113 vs. 2523 ± 111 ml, d = 0.19) and also in the control group 301 no differences in RBCV (2546 ± 98 vs. 2511 ± 95 ml, d = 0.13) were observed, as there was no main 302 effect of time (P = 0.22) or intervention (P = 0.93), and no interaction (P = 0.95) of the two from pre to 303 post. 304
Although there was a significant time*intervention interaction (P < 0.05) with no main effect for time (P 305 = 0.59) and intervention (P = 0.68) for total BV, the post hoc analysis for the experimental group revealed 306 no significantly increased total BV after heat training (5916 ± 210 vs. 6111 ± 257 ml, P = 0.12, d = 0.31). 307
Also in the control group BV remained unchanged from pre to post training (6089 ± 200 vs. 5949 ± 187 308 ml, P = 0.25, d = 0.26). 309
310
Effects of heat training on cardiovascular and thermoregulatory parameters 311
Detailed cardiovascular and thermoregulatory responses of all exercise tests are provided in table 2. 312
Briefly, in both, the experimental and the control group, training did not lead to an altered Q max or SV max . 313 T rec in the T38 trials was always elevated to the same initial temperature by water immersion and 314 therefore resting T rec did not differ from pre to post training. In contrast, we did not control for T rec in the 315 T18 trials and therefore participants' resting T rec varied by approximately 0.25 ± 0.04 °C (main effect of 316 time P < 0.05). However, no significant time*intervention interaction could be found due to similar 317 changes in the exercise and the control group. The same was true for maximal T rec but only in the Time 318
Trial test. Statistical analysis revealed no other significant training induced changes in any of the 319 measured parameters. 320 321
Effects of heat training on ventilation, mean arterial pressure and cerebral perfusion 322
Exposure to heat (T38) increased (P < 0.05) ventilation (VE) compared to the T18 trial ( Figure 5A ). For 323 both the T18 and the T38 trial a significant main effect for time and intensity was found, however, VE 324 response to training was not different between the control and the experimental group since no significant 325 interaction between time, intensity and intervention was observed for T18 and T38. 326 MAP was reduced (P < 0.05) in the T38 compared to T18 trials ( Figure 5B ). In the T38 trial, after a 327 significant time*intervention interaction, post-hoc analysis revealed a significantly increased (P < 0.05) 328 MAP after training for the experimental but not for the control group (P = 0.98). For the T18 trial no such 329 differences between the experimental and the control group could be demonstrated. 330
Delta MCAv mean (% baseline) for both groups are displayed in Figure 5C . Compared to the control group, 331 in the experimental group % baseline MCAv mean was significantly enhanced (P < 0.05) after heat training 332 in the T38 trial but not in the T18 trial. In absolute terms, resting and maximal MCAv mean was reduced (P 333 < 0.05) from 55.5 ± 3.0 to 42.3 ± 2.9 and from 69.6 ± 5.7 to 52.5 ± 3.4 cm.s -1 , respectively in T38 334 compared to T18. In the experimental group exercise training increased (P < 0.05) MCAv mean in T38 and 335 reached similar absolute resting and maximal values as in the T18 trial. 336
In line with a reduced MCAv mean cerebral oxygenation was also decreased (P < 0.05) in the T38 compared 337 to the T18 trials in both the experimental and the control group ( Figure 5D ). However, the enhanced 338
MCAv mean after heat training did not improve cerebral oxygenation and also in the control group cerebraloxygenation remained unchanged in the T18 and the T38 trial since neither the main effects for time and 340 intervention nor any interaction was significant. 341 Cerebrovascular conductance (CVC; MCAv mean /MAP) demonstrated no significant change from pre to 342 post heat acclimation in the T38 trial (P = 0.08 for time, P = 0.27 for intervention, P = 0.85 for 343 time*intervention). In the T18 trial a main effect of time could be observed (P < 0.05), however no 344 significant interaction between time and intervention was demonstrated (P = 0.26). 
Level of heat acclimation 372
Heat acclimation largely depends on the magnitude of heat stress, duration of exposures, frequency and 373 total number of stimuli but it is also well accepted that most adaptations to heat stress are completed after 374 7-10 days of daily exposure (46). Typical indicators that sufficient heat acclimation has occurred include 375 a reduced HR, T core and sweat electrolyte concentration but also an increased PV and sweat output. In the 376 present study we decided to passively pre-heat participants before the maximal incremental exercise and 377 the Time Trial tests to always have the same initial T rec . This experimental approach allowed us to 378 examine the impact of heat acclimation at standardized heat strain conditions. This approach furthermore 379 assured that participants initiated all exercise tests in a hyperthermic condition since V O 2 max might be 380 maintained with heat exposure if initiated with a 'normothermic' body temperature and also Time Trial 381 performance in the heat might remain unaltered for the first minutes (30). As will be discussed later we 382 also applied this approach to have a similar study design to that of Lorenzo and co-workers (21). In 383 contrast, choosing such study design will most likely have blunted the potential acclimation induced 384 reductions in submaximal T rec and HR. However, since we observed an increase in PV and sweat output 385 and a concomitant reduction in sweat [Na + ] together with an improved exercise performance at 38 °C we 386 are confident that significant heat acclimation has taken place in the study participants. 387
Exercise performance in 18 and 38 °C following heat training 389
As expected (21, 45), in passively pre-heated participants, acute heat exposure led to a 4.1 ± 1.4 and 13.1 390 ± 2.9 % reduction in V O 2 max and Time Trial performance, respectively. Also, the observed increase in 391 V O 2 max and Time Trial performance corresponding to 9.6 ± 2.1 and 10.4 ± 3.1 % following heat training 392 concurs with previous findings (21, 22) . Of note is that the increase in V O 2 max fully compensated the 393 initial heat induced decrement and also W max and P avg after heat training were almost completely restored 394 to levels initially obtained at 18 °C. So far this has only been observed in the field (34). Collectively, the 395 accumulated evidence emphasizes the need for heat acclimation to maximize performance in a hot 396 environment and furthermore, suggests that acclimation can at least be acquired partially without 397 traveling to the site of competition. However, heat training in the present study did not facilitate exercise 398 performance when tested in 18 °C ambient conditions. In a recent review Corbett et al. (6) analyzed 399 several studies investigating the effects of acclimation on exercise performance in temperate and cold 400 conditions. Although some studies have reported an ergogenic effect of acclimation, most of the findings 401 have been confounded by several factors such as the absence of a control group, the inclusion of untrained 402 subjects, sub-optimal acclimation programs or the application of an unclear study design. The most 403 convincing study mentioned in this review was conducted by Lorenzo et al. (21) . Although we applied a 404 similar study design, they found heat training induced gains of 5 and 6 % for V O 2 max and Time Trial 405
performance, respectively, when tested at 13 °C (21) which contrasts our study. In this regard, it seems 406 unlikely that such divergence in performance is related to the temperature difference (18 °C vs 13 °C) in 407 which the participants were tested (16). In addition, the degree of adaptations to heat exposure has 408 previously been linked to training status (41). Nonetheless, the participants in the latter study were well 409 trained (V O 2 max ≈ 67 ml.min -1 .kg -1 ) and hence of similar fitness levels to the volunteers included in the 410 present study (V O 2 max ≈ 61 ml.min -1 .kg -1 ). Otherwise, it is noteworthy that in the aforementioned study 411 (21) the training sessions in the heat were conducted at a relatively higher exercise intensity when 412 compared to the training conducted in the control trials. In the present study all trainings were matched toelicit the same relative cardiovascular strain. Although the difference was rather small (~ 20 %) this may 414 explain, at least in part, the difference in study outcomes. The finding that exercise performance following 415 heat acclimatization is not enhanced in a temperate environment is in agreement with a controlled study 416 performed in competitive cyclists (V O 2 max ≈ 63 ml.min -1 .kg -1 ) (16). Here it was demonstrated that 417 compared to control training no additional benefit of two weeks of heat training was apparent when tested 418 in 5 -13 °C whereas an expected effect was observed when the exercise tests were conducted at 35 °C. 419
Lorenzo and co-workers (21) speculated that the observed increase in PV (estimated from changes in Htc) 420 of ≈ 200 ml could have facilitated exercise capacity in 13 °C. Herein, the heat training induced increase in 421 PV of 201 ± 88 ml did not facilitate exercise performance in 18 °C, which adds to the controversy on 422 whether PV expansion facilitates V O 2 max or Time Trial performance in temperate conditions (7, 47) . 423
While there is little doubt that PV expansion can enhance Q max (3), the concomitant induced hemodilution 424 has to be counterbalanced by an even greater increase in Q max in order to increase exercise performance. 425
In the present study the increase in PV of 15.7 ± 0.6 % led to an 18.2 ± 2.1 % increase in Q max and a 426 concomitant 8.2 ± 0.1 % reduction in Hct. Furthermore, as will be discussed below, the expansion of PV 427 did not enhance exercise performance in a hot environment (48). 428 Therefore, if applying an appropriate study design and controlling for training load, we suggest that heat 429 training does not facilitate exercise performance in a temperate environment any more than ordinary 430 exercise training does. 431
432
Heat training-induced increase in plasma volume and exercise performance in the heat 433
The first speculations that BV might increase in response to a rise in ambient temperature is believed to 434 date back to 1923 (2). Since then, numerous studies have confirmed that exposure to warm environments 435 increases PV after a few days of acclimation, and even so if the length of heat exposure is as little as 1 436 hour/day (23, 24, 40, 49) . Hypervolemia is often suggested to be the most important feature of heat 437 acclimation (24, 40). In the current study heat training augmented PV by 6 ± 2 % which is in agreement 438 with previous findings (21, 23). PV was not increased in the control group. In previously untrained 439 individuals, PV usually increases within a few days of exercise training regardless of the thermal 440 environment (1, 14) . The reason for the control training not to expand PV is likely related to the already 441 relative fit status of the included participants. Moreover, in the current study, the heat training-induced 442 increase in resting PV was not statistically associated with the concomitantly occurring improvements in 443 W max , V O 2 max or Time Trial performance which is in line with previous findings (32, 33). However, 444 these studies also reported significant correlations between acclimatization induced changes in exercise 445 performance and dynamic changes in PV while exercising in the heat, suggesting that PV retention during 446 exercise is more important than absolute resting PV. Of note is that whereas V O 2 max when tested in 38 447 °C was increased by 9 % following heat training, Q max remained nearly unchanged (21.3 to 21.7 l.min -1 ). 448
Since maximal O 2 extraction across the exercising skeletal muscle is reported unchanged following heat 449 training (23, 24) we assume that the ≈ 400 ml numerical higher Q max may at least be partially responsible 450 for the increase in V O 2 max, but that statistical power may have lacked to establish this association. We 451 acknowledge, that 400 ml of extra Q max can not explain the entire 400 ml elevation in V O 2 max, we can 452 however not account for the remaining part. The modest increase in Q max was likely the result of the also 453 modest increase in PV (≈ 200 ml) whereas in a previous study the removal of 382 ml of whole blood 454 reduced Q max by 2.3 l.min -1 (3). In the present study the acute expansion of PV by 538 ± 16 ml (15 %) of 455 albumin solution did not facilitate exercise performance with acute heat exposure, which is in agreement 456 with the only previous study that applied a similar experimental approach (48). Nevertheless, in the 457 present study PV expansion by albumin led to an increase in submaximal and maximal SV and Q . We 458 speculate that V O 2 max and Time Trial performance were not enhanced despite these improvements since 459 PV expansion also prompted a 8 % reduction of Htc, and thereby likely offset some of the potential blood 460 flow-dependent improvements in O 2 transport to the exercising skeletal muscles. An interesting pointwould be to see whether artificial PV expansion might have a different influence on highly dehydrated 462 subjects, where hemoconcentration has occurred. Indication therefore is given by the fact that fluid 463 ingestion during exercise in the heat decelerates fatigue. Dehydration induced reduction in skin and 464 locomotor muscle blood flow rapidly lowers O 2 delivery to the exercising legs and the capacity of heat 465 dissipation (11). Therefore, a higher PV might have a beneficial effect on exercise capacity by increasing 466 blood flow to the important organs without lowering Hct. However, this remains to be established. 467
468
Acclimation induced normalization of cerebral perfusion (i.e. MCAv mean ) and its relation to exercise 469 performance 470
As expected (26), acute exposure to 38 °C reduced MCAv mean during exercise, whereas heat training 471 facilitated MCAv mean during exercise at 38 °C to such an extent that it became restored to levels observed 472 with exercise at 18 °C. This has not been demonstrated previously. MCAv mean is regulated by various 473 factors where, PaCO 2 (ventilation) and MAP are the most important ones (31). VE was not reduced with 474 heat training and was hence not associated with the reduction in MCAv mean (R = 0.23) which is in line 475 with previous findings (10). On the other hand we found MAP to be increased with heat training. With 476 exercise in the heat, blood flow to the skin is facilitated to favor cooling (12, 36) , and this will inevitably 477 lead to a reduction in blood availability for other organs such as the brain (26). It could hence be 478 speculated that the increase in plasma volume observed with heat training could lead to increased MAP, 479 restored cerebral perfusion and preserved skin perfusion, although this depends on the interplay between 480 the degree of vasodilation and the volume increase in plasma In the present study, the association between 481 increases in PV and MCAv mean and PV and MAP was R = 0.26 and R = 0.20 (P = 0.57 and P = 0.43), 482 respectively, with a tendency for a moderate association between MCAv mean and MAP (R = 0.41, P = 483 0.07). Therefore, the mechanisms facilitating MCAv mean with heat acclimation could not be determined. 484
Nonetheless, it should be noted that CVC was not different between pre and post heat acclimationmeasurements. Hence, when accounting for MAP, heat acclimation does not alter MCAv mean which 486 suggests that changes in MCAv mean can be mainly be attributed to changes in MAP. 487
An augmented MCAv mean could facilitate exercise capacity by several mechanisms. Cerebral hypoxemia 488 has been suggested to facilitate centrally mediated fatigue (35), and a restoration of cerebral oxygenation 489 secondary to enhancing brain blood flow has hence been proposed as a candidate to facilitate exercise 490 performance. However, although the proposed mechanism has received much attention within the last 491 decade (26, 27, 35) , in studies in which MCAv mean and cerebral oxygenation have been increased by the 492 administration of small volumes of CO 2 to the inspiration in hypoxia, this has not improved exercise 493 performance (8, 43), also with additional heat exposure (17). It has to be mentioned that when artificially 494 manipulating cerebral blood flow (e.g. with CO 2 ), simultaneously other factors such as pH, ventilation 495 and breathing resistance will be affected which all could negatively influence exercise performance. 496
Alternatively an improved cerebral perfusion has been suggested to favor cooling of the brain (28) and 497 thereby improve exercise capacity in the heat but this cannot be addressed in the current study. 498
As mentioned, MAP was reduced at 38 °C in the study participants. MAP is generally reported being 499 maintained with heat exposure until dehydration occurs (13). Although we cannot exclude that 500 dehydration may have occurred this seems unlikely since the duration of the V O 2 max test was less than 501 20 minutes. One possible explanation for the reduced MAP could be related to our pre-heating protocol 502 where participants intentionally initiated the exercise tests hyperthermic which in turn could have 503 decreased MAP. However, since this observation was similarly present before and after the training and 504 in the experimental and the control group it should not have influenced our finding that MAP was 505 increased by heat training. 506
507
Heat training facilitated sweat rate and lowered sweat electrolyte concentration and their effect on 508 exercise performance in the heat 509
With heat training a substantial increase in sweat output (+ 26 ± 6 %) and decrease in sweat [Na+] (-19 ± 510 7 %) occurred. This is in line with previous research (16, 24) , and indicates that substantial heat 511 acclimation had occurred. Despite that these have previously been suggested to facilitate exercise 512 performance in the heat, no such correlations could be established in the current study. It could be 513 speculated however that at least the more diluted sweat could become advantageous especially for longer 514 lasting submaximal events. It also needs to be mentioned that the increased sweat output likely minimally 515 increased evaporative heat loss since sweat rate was certainly beyond the maximal evaporative capacity of 516 a 38 °C environment (i.e. low sweating efficiency). 517
518
Limitations to the study 519
Due to the limited sample size, it cannot be ruled out that a statistical type II error prevented the 520 correlational analysis to reveal associations between the observed performance gains and the measured 521 physiological variables which also applies to the ANOVA testing. As already mentioned, since we raised 522 the participants' T rec to always the same initial value, part of the potential adaptations, such as 523 submaximal T core and HR, may have become blunted. Furthermore, a possible acclimation decay has to be 524 considered. Although the T38 trial was deliberately conducted before the T18 trial to have an additional 525 heat stimulus during the 4 -5 d post-testing period it can not be excluded that partial de-acclimation in 526 the T18 trial has occurred and therefore influenced our results. Other limitations to the study are that the 527 included study volunteers were not blinded towards the treatment. It is however virtually impossible to 528 blind humans when it comes to heat exposure, and the use of a cross-over study design was judged the 529 best solution. It would have been advantageous to blind the investigators towards the treatment also, but 530 due to staff limitations this was unfortunately impossible. Furthermore, it has to be mentioned that the 531 artificial PV increase was higher (15 %) than the actual heat training induced increase (6 %). The aim was 532 to expand PV equal to or more than what normally occurs with heat training since if we were to expand 533 by too little a negative result could be argued to derive from too little of an expansion. Some of our study 534 participants displayed an increase in PV of up to 13.5 % which further strengthens this assumption. 535
However, we acknowledge that the higher PV infusion might have led to such hemodilution which might 536 have offset a potential beneficial effect of an elevated Q . Besides, it needs to be acknowledged that 537
MCAv mean is only a surrogate measure of cerebral perfusion and that hyperthermia induced 538 vasconstriction may have influenced those results. Also the recording of cerebral oxygenation (NIRS) in 539 the heat proves to be challenging and has to be interpreted with caution. Interfering sweat can cause 540 missing values and also skin blood flow may have introduced bias as this greatly influences cerebral 541 NIRS signal (44). Furthermore, it needs to be acknowledged that also the measurement of Q max with the 542
Innocor device has its limitations since it highly depends on the participants' ability to follow the given 543 breathing pattern. Recently however, we demonstrated the devices ability for repeated measures (42). 544
Lastly, as already mentioned, it has to be acknowledged that in some participants not allowing drinking 545 might have led to hypohydration even though exercise tests were always initiated well hydrated. 546
547
The novel findings of the present study are that 10 days of heat training facilitated exercise performance 548 in the heat but not in temperate conditions. Furthermore, adaptations in PV, sweat output and sweat [Na + ] 549 and cerebral perfusion which have previously been proposed to facilitate exercise performance in the heat 550
were not associated with the observed gains in performance. Lastly, in well trained subjects acute 551 expansion of plasma volume with albumin infusion did not facilitate exercise performance in 38 °C. Time Trial test  T18  T38  T38 A  T18  T38  T38 A  Resting T rec , °C 38.0 ± 0.1 
